Development of antimalarial human monoclonal antibodies against Plasmodium falciparum by Wang, LT

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults by Silk, SE, Kalinga, WF, Mtaka, IM, Lilolime, NS, Mpina, M, Milando, F, Ahmed, S, Diouf, A, Mkwepu, F, Simon, B, Athumani, T, Rashid, M, Mohammed, L, Lweno, O, Ali, AM, Nyaulingo, G, Mwalimu, B, Mswata, S, Mwamlima, TG, Barrett, JR, Wang, LT, Themistocleous, Y, King, LDW, Hodgson, SH, Payne, RO, Nielsen, CM, Lawrie, AM, Nugent, FL, Cho, J-S, Long, CA, Miura, K, Draper, SJ, Minassian, AM, Olotu, AI

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype by Barrett, JR, Pipini, D, Wright, ND, Cooper, AJR, Gorini, G, Quinkert, D, Lias, AM, Davies, H, Rigby, CA, Aleshnick, M, Williams, BG, Bradshaw, WJ, Paterson, NG, Martinson, T, Kirtley, P, Picard, L, Wiggins, CD, Donnellan, FR, King, LDW, Wang, LT, Popplewell, JF, Silk, SE, de Ruiter Swain, J, Skinner, K, Kotraiah, V, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Minassian, AM, Lauffenburger, DA, Miura, K, Long, CA, Wilder, BK, Koekemoer, L, Tan, J, Nielsen, CM, McHugh, K, Draper, SJ